Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

62
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
62
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

33
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
33
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

48
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
48
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

58
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
58
Autoimmune Disorders01:29

Autoimmune Disorders

720
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
720
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

47
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Management of patients with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy.

Current opinion in rheumatology·2026
Same author

Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

ACR open rheumatology·2025
Same author

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Arthritis care & research·2025
Same author

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.

Arthritis care & research·2025

Related Experiment Video

Updated: Oct 2, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.1K

Systemic Lupus Erythematosus Management in Pregnancy.

Kathryn H Dao1, Bonnie L Bermas1

  • 1Division of Rheumatic Diseases, UTSouthwestern Medical Center, Dallas, TX, USA.

International Journal of Women'S Health
|February 25, 2022
PubMed
Summary

Systemic lupus erythematosus (SLE) management in pregnancy requires careful planning. Optimal outcomes involve controlling SLE before conception and using pregnancy-compatible medications, including hydroxychloroquine and aspirin, to minimize risks.

Keywords:
fertilitymedicationspregnancysystemic lupus erythematosus

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.0K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K

Related Experiment Videos

Last Updated: Oct 2, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.1K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.0K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K

Area of Science:

  • Reproductive immunology
  • Maternal-fetal medicine
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) significantly impacts women of reproductive age.
  • Pregnancy in SLE patients carries risks of disease flares and adverse maternal-fetal outcomes.
  • Specific autoantibodies (antiphospholipid, anti-Ro/SSA, anti-La/SSB) confer unique risks during pregnancy.

Purpose of the Study:

  • To outline family planning considerations for women with SLE.
  • To review pregnancy risks associated with SLE and specific autoantibodies.
  • To provide guidance on medication management for SLE patients planning pregnancy.

Main Methods:

  • Literature review of SLE in pregnancy and medication safety.
  • Analysis of risks associated with SLE disease activity and autoantibodies.
  • Recommendations for preconception counseling and management during pregnancy.

Main Results:

  • SLE flares during pregnancy can increase risks of fetal loss, pre-eclampsia, preterm birth, and fetal growth restriction.
  • Antiphospholipid antibodies are linked to thrombosis and fetal loss.
  • Anti-Ro/SSA and anti-La/SSB antibodies pose risks for congenital heart block and neonatal lupus.
  • Hydroxychloroquine is recommended for all SLE patients; aspirin may reduce pre-eclampsia risk.
  • Certain immunosuppressants (azathioprine, tacrolimus, cyclosporine) and biologics (rituximab, belimumab, abatacept) are compatible with pregnancy/lactation, while others (MMF, methotrexate, leflunomide, cyclophosphamide) are not.

Conclusions:

  • Preconception disease control and use of pregnancy-compatible medications are crucial for favorable outcomes in SLE pregnancies.
  • Continuous monitoring and tailored medication strategies are essential throughout pregnancy for SLE patients.
  • Informed family planning and medication management optimize maternal and fetal health in women with SLE.